Cytomegalovirus (CMV) CD8 t-cell immune competence, quantitative assessment by Flow Cytometry-994

Test info

  
Cytomegalovirus (CMV) CD8 t-cell immune competence, quantitative assessment by Flow Cytometry
  
994
  
LAB994
  
MSO
  
CMV (Cytomegalovirus)
Cytomegalic inclusion disease (CMID)
Cytomegalovirus (CMV)
CMID (Cytomegalic Inclusion Disease)
  
  • Assessing cytomegalovirus (CMV)-specific immune competence in allo-hematopoietic stem cell transplantation patients who are at risk for developing late CMV disease (beyond day 100 after transplant)
  • Assessing CMV-specific immune competence in solid organ transplant patients who are at high risk for CMV reactivation post-transplant
  • Monitoring immune competence in patients post-primary CMV infection after transplant who are at risk for CMV reactivation after the cessation of antiviral prophylaxis
  • Identifying individuals who are likely to be protected from post-transplant CMV infection and those who are at higher risk of CMV reactivation
  • The global CD8 T cell immune competence assay is useful for determining over immunosuppression within the CD8 T cell compartment, when used on transplant recipients and patients with autoimmune disorders receiving therapy with immunosuppressant agents

Specimen

  
Sodium heparin (Na hep) whole blood
  
  
20 mL
  
10 mL
  

Do not spin; submit specimen in original collection tube

  

Dk green Sodium heparin (Na hep), no gel

  

Ambient - 48 hours

Specimens are required to be received in the laboratory weekdays and by 4 p.m. on Friday. It is recommended that specimens arrive within 24 hours of draw.

Performance

  
Mayo Clinic Laboratories (CMVC8): R-NX
  
Mo - Fr
  
3 - 6 days
  

Flow Cytometry

Clinical and Interpretive info

  

See report

Billing

  
86356 x6
86359
86352
  
Yes
  

Tracking

  
06/13/2019
  
06/13/2019